Objective:To provide the first large single-operator case series of patients who undergo“en bloc”thulium laser enucleation of the prostate(ThuLEP)and to demonstrate an improvement in enucleation efficacy with experi...Objective:To provide the first large single-operator case series of patients who undergo“en bloc”thulium laser enucleation of the prostate(ThuLEP)and to demonstrate an improvement in enucleation efficacy with experience.Methods:We prospectively evaluated a cohort of patients with symptomatic benign prostatic hyperplasia(BPH)who underwent“en bloc”ThuLEP between May 2015 and November 2017.Association between dependent variables(delivered energy and operating time)and independent variables(adenoma volume and experience)were estimated with regression analysis.The experience was calculated as the time interval between the date of the first operation of the series and the date of the operation being considered.Results:A total of 100 patients were registered for the study.Median operative time was 56.5 min(interquartile range[IQR]:40-85 min).Median enucleation time was 17.4 min(IQR:15-21.5 min).Median enucleation index(enucleation time per adenoma gram)was 0.3 min/g(0.2-0.3 min/g).The overall operative time is not influenced by experience,but we registered a significant trend towards a reduction in the total amount of energy delivered energy normalized per adenoma gram(p=0.0148).Conclusion:We believe that further attention is needed for these new“en bloc”prostatic enucleation techniques,which can facilitate some surgical steps,leading to a widespread use of laser technology for BPH surgical treatment.展开更多
Treatment of patients with lower urinary tract symptoms （LUTS） secondary to benign prostatic hyperplasia （BPH） may affect the quality of sexual function and ejaculation. The effect of new surgical procedures, whic...Treatment of patients with lower urinary tract symptoms （LUTS） secondary to benign prostatic hyperplasia （BPH） may affect the quality of sexual function and ejaculation. The effect of new surgical procedures, which are currently available to treat BPH, on erection and ejaculation, has been poorly studied. This study aimed to assess the effect of thulium laser enucleation of the prostate （ThuLEP） on sexual function and retrograde ejaculation in patients with LUTS secondary to BPH. We performed a prospective study in 110 consecutive patients who had undergone ThuLEP to analyze changes in sexual function and urinary symptoms. To evaluate changes in erection and ejaculation, and the effect of urinary symptoms on the quality of life （QoL）, five validated questionnaires were used： the ICIQ-MLUTSsex, MSHQ-EjD, International Index of Erectile Function 5, International Prognostic Scoring System （IPSS） questionnaire, and QoL index of the intraclass correlation coefficients. Patients also underwent IPSS and flowmetry to assess the outcome of flow. Patients were evaluated before surgery and 3-6 months after ThuLEP, whereas those with previous abdominal surgery were excluded. The patients＇ mean age was 67.83 years. Postoperative urinary symptoms improved after surgery. No significant differences in erectile function before and after surgery were observed. As compared with other techniques described in the literature, the percentage of patients with conserved ejaculation increased by 52.7% after ThuLEP. ThuLEP positively affects urinary symptoms and their effect on the QoL of patients as assessed by questionnaire scores. While endoscopic management of BPH （e.g. transurethral resection of the prostate） causes retrograde ejaculation in most patients, those who undergo ThuLEP have conserved ejaculation and erectile function.展开更多
Objective:The aim of this research was to evaluate the efficiency of reciprocating morcellation for removing giant benign prostatic hyperplasia during holmium laser enucleation of the prostate,investigate whether perf...Objective:The aim of this research was to evaluate the efficiency of reciprocating morcellation for removing giant benign prostatic hyperplasia during holmium laser enucleation of the prostate,investigate whether performing morcellation as a two-stage procedure improves tissue retrieval efficiency,and seek to determine the optimal interval between the two surgeries.Methods:This study included nine cases of holmium laser enucleation of the prostate with an enucleated prostate weight exceeding 200 g,indicative of substantial prostate enlargement.Morcellation was performed on Day 0(n=4),Day 4(n=1),Day 6(n=1),and Day 7(n=3).The intervals were compared regarding the morcellation efficiency,beach ball presence,and pathology.Results:The mean estimated prostate volume was 383(range 330e528)mL;the median enucleation weight was 252(interquartile range[IQR]222,342)g;and the median enucleation time was 83(IQR 62,100)min.The mean morcellation efficiency was 1.44(SD 0.55)g/min on Day 0 and 13.69(SD 2.46)g/min on day 7.The morcellation efficiency was 4.15 g/min and 10.50 g/min on Day 4 and Day 6,respectively,with significantly higher in the two-stage group compared to one-stage group(11.0 g/min vs.1.5 g/min;p=0.014).Efficiency was strongly correlated with intervals(p<0.001);the incidences of beach balls were 100%(4/4)and 60%(3/5)in the immediate and two-stage surgery groups,respectively.Conclusion:The efficiency of two-stage morcellation with reciprocating morcellators was highly related to the postoperative interval,with the maximum efficiency reached on Day 7.展开更多
Two-micron （thulium） laser resection of the prostate-tangerine technique （TmLRP-TT） is a transurethral procedure that uses a thulium laser fiber to dissect whole prostatic lobes off the surgical capsule, similar t...Two-micron （thulium） laser resection of the prostate-tangerine technique （TmLRP-TT） is a transurethral procedure that uses a thulium laser fiber to dissect whole prostatic lobes off the surgical capsule, similar to peeling a tangerine. We recently reported the primary results. Here we introduce this procedure in detail. A 70-W, 2-um （thulium） laser was used in continuous-wave mode. We joined the incision by making a transverse cut from the level of the verumontanum to the bladder neck, making the resection sufficiently deep to reach the surgical capsule, and resected the prostate into small pieces, just like peeling a tangerine. As we resected the prostate, the pieces were vaporized, sufficiently small to be evacuated through the reseetoscope sheath, and the use of the mechanical tissue morcellator was not required. The excellent hemostasis of the thulium laser ensured the safety of TmLRP-TT. No patient required blood transfusion. Saline irrigation was used intraoperatively, and no case of transurethral resection syndrome was observed. The bladder outlet obstruction had clearly resolved after catheter removal in all cases. We designed the tangerine technique and proved it to be the most suitable procedure for the use of thulium laser in the treatment of benign prostatic hyperplasia （BPH）. This procedure, which takes less operative time than standard techniques, is safe and combines efficient cutting and rapid organic vaporization, thereby showing the great superiority of the thulium fiber laser in the treatment of BPH. It has been proven to be as safe and efficient as transurethral resection of the prostate （TURP） during the 1-year follow-up.展开更多
BACKGROUND Primary prostate Burkitt's lymphoma is a rare and aggressive condition with a poor prognosis.Its clinical presentation can be challenging to differentiate from benign prostatic hyperplasia.Given the rar...BACKGROUND Primary prostate Burkitt's lymphoma is a rare and aggressive condition with a poor prognosis.Its clinical presentation can be challenging to differentiate from benign prostatic hyperplasia.Given the rarity of primary prostate Burkitt's lymphoma,its diagnosis and treatment remain unclear.CASE SUMMARY This report presents a case of a 57-year-old male with primary prostate Burkitt's lymphoma,initially misdiagnosed as prostatic hyperplasia.This case's operative process,intraoperative findings and postoperative management are discussed in detail.CONCLUSION Primary prostate lymphoma is difficult to distinguish from other prostate diseases.Holmium laser enucleation of the prostate(HoLEP),a minimally invasive procedure,is crucial in diagnosing and treating this rare disease.Clinicians should remain vigilant and thoroughly combine physical examination,imaging and test results when encountering patients of younger age with small prostate size but a rapid progression of lower urinary tract symptoms.HoLEP is an essential diagnostic and therapeutic tool in managing primary prostate Burkitt's lymphoma.展开更多
Objective:We aimed to determine safety and feasibility of thulium laser transurethral vapoenucleation of prostate(ThuVEP)for treatment of obese patients affected by benign prostatic hyperplasia(BPH).Methods:We retrosp...Objective:We aimed to determine safety and feasibility of thulium laser transurethral vapoenucleation of prostate(ThuVEP)for treatment of obese patients affected by benign prostatic hyperplasia(BPH).Methods:We retrospectively analysed data of 452 patients with BPH who underwent ThuVEP from February 2012 to March 2016 in a single center.Patients were divided into three groups according to body mass index(BMI,kg/m^2):Normal weight(18.5≤BMI<25;Group A),overweight(25≤BMI<30;Group B)and obese(BMI≤30;Group C),for a total of 412 patients evaluable for this study.Preoperative total serum prostate-specific antigen(PSA),digital rectal examination of the prostate,transrectal ultrasound(TRUS),renal ultrasound,urine culture,uroflowmetry,International Prostate Symptoms Score(IPSS),and Quality of Life(QoL)score were analyzed.Post-operative complications,hospital stay and days of catheterization,questionnaires and uroflowmetry at 1 and 3 months after surgery were evaluated.Preoperative data,surgical outcomes,complication rate and clinical outcomes were compared between groups.Results:The median age of patients was 69 years(Interquartile Range[IQR 10]).The preoperative median IPSS among groups was 19(IQR 8.75),20(IQR 10),and 18(IQR 10)respectively.At 1 and 3 months of follow-up,this value was 8(IQR 7),8(IQR 4),7(IQR 5)and 5(IQR 6.25),5(IQR 6),6(IQR 5),respectively(all p between groups>0.05).There was no statistically significant difference among three groups as for hospital stay and days of catheterization(p>0.05).Conclusion:Our results showed that ThuVEP was safe and feasible even in overweight patients with substantially enlarged prostate.展开更多
Objective To investigate the feasibility and efficacy of transurethral prostate enucleation with 2 μm laser in treatment of benign prostatic hyperplasia ( BPH) . Methods One hundred and seven patients with BPH were t...Objective To investigate the feasibility and efficacy of transurethral prostate enucleation with 2 μm laser in treatment of benign prostatic hyperplasia ( BPH) . Methods One hundred and seven patients with BPH were treated by transurethral prostate enucleation with 2 μm la-展开更多
We aim to evaluate the incidence of incontinence following laser endoscopic enucleation of the prostate(EEP)comparing en-bloc(Group 1)versus 2-lobe/3-lobe techniques(Group 2).We performed a retrospective review of pat...We aim to evaluate the incidence of incontinence following laser endoscopic enucleation of the prostate(EEP)comparing en-bloc(Group 1)versus 2-lobe/3-lobe techniques(Group 2).We performed a retrospective review of patients undergoing EEP for benign prostaticenlargement in 12 centers between January 2020 and January 2022.Data were presented as median and interquartile range(IQR).Univariable and multivariable logistic regression analysis was performed to evaluate factors associated with stress urinary incontinence(SUI)and mixed urinary incontinence(MUI).There were 1711 patients in Group 1 and 3357 patients in Group 2.Patients in Group 2were significantly younger(68[62–73]years vs 69[63–74]years,P=0.002).Median(interquartile range)prostate volume(PV)wassimilar between the groups(70[52–92]ml in Group 1 vs 70[54–90]ml in Group 2,P=0.774).There was no difference in preoperativeInternational Prostate Symptom Score,quality of life,or maximum flow rate.Enucleation,morcellation,and total surgical time weresignificantly shorter in Group 1.Within 1 month,overall incontinence rate was 6.3%in Group 1 versus 5.3%in Group 2(P=0.12),and urge incontinence was significantly higher in Group 1(55.1%vs 37.3%in Group 2,P<0.001).After 3 months,the overall rate ofincontinence was 1.7%in Group 1 versus 2.3%in Group 2(P=0.06),and SUI was significantly higher in Group 2(55.6%vs 24.1%in Group 1,P=0.002).At multivariable analysis,PV and IPSS were factors significantly associated with higher odds of transient SUI/MUI.PV,surgical time,and no early apical release technique were factors associated with higher odds of persistent SUI/MUI.展开更多
Objective:Urethral stricture disease after endo-urological treatment of benign prostatic hyperplasia(BPH)is a sparsely described complication.We describe management of five categories of these strictures in this retro...Objective:Urethral stricture disease after endo-urological treatment of benign prostatic hyperplasia(BPH)is a sparsely described complication.We describe management of five categories of these strictures in this retrospective observational case series.Methods:One hundred and twenty-one patients presenting with symptoms of bladder outflow obstruction after endo-urological intervention for BPH from February 2016 to March 2019 were evaluated.Among them,76 were eligible for this study and underwent reconstructive surgery.Preoperative and postoperative assessments were done with symptom scores,uroflowmetry,ultrasound for post-void residue,and urethrogram.Any intervention during follow-up was classed as a failure.The recurrence and 95%confidence interval for recurrence percentage were calculated.Results:The following five categories of patients were identified:Bulbo-membranous(33[43.4%]),navicular fossa(21[27.6%]),penile/peno-bulbar(8[10.5%]),bladder neck stenosis(6[7.9%]),and multiple locations(8[10.5%]).The average age was 69 years(range:60-84 years).Overall average symptom score,flow rate,and post-void residue changed from 21 to 7,6 mL/s to 19 mL/s,and 210 mL to 20 mL,respectively.The average follow-up was 34 months(range:12-58 months).Overall recurrence and complication rates were 10.5%and 9.2%,respectively.The recurrence in each category was seen in 3,1,2,1,and 1 patient,respectively.Overall 95% confidence interval for recurrence percentage was 4.66-19.69.Conclusion:Urethral stricture disease is a major long-term complication of endo-urological treatment of BPH.The bulbo-membranous strictures need continence preserving approach.Navicular fossa strictures require minimally invasive and cosmetic consideration.Peno-bulbar strictures require judicious use of grafts and flaps.Bladder neck stenosis in this cohort could be treated with endoscopic measures.Multiple locations need treatment based on their sites in single-stage as far as possible.展开更多
Objective:Minimally invasive treatments for benign prostatic hyperplasia (BPH) have seen an increase in usage in recent years. We aimed to determine what types of events may influence patient search habits related to ...Objective:Minimally invasive treatments for benign prostatic hyperplasia (BPH) have seen an increase in usage in recent years. We aimed to determine what types of events may influence patient search habits related to surgical BPH treatments.Methods:Google Trends was used to determine the frequency of searches for different minimally invasive and prostatic ablative treatments for BPH in the United States. The procedures including transurethral resection of the prostate (TURP), Aquablation therapy (Aquablation), Greenlight laser therapy (Greenlight), transurethral needle ablation, transurethral microwave thermotherapy, Urolift (prostatic urethral lift [PUL]), Rezum, iTind, holmium laser enucleation of the prostate, simple prostatectomy, and prostatic artery embolization were compared.Results:From January 1, 2004 to February 28, 2023, the number of internet search queries have increased for TURP, PUL, Rezum, prostatic artery embolization, and holmium laser enucleation of the prostate. There has been a slight decrease in searches for Greenlight, transurethral needle ablation, transurethral microwave thermotherapy, iTind, simple prostatectomy, and Aquablation.Conclusion:Despite increased searches of alternatives, TURP remains the most searched BPH procedure. Additionally, search habits may be influenced by several factors including government approval, corporate acquisition, and marketing campaigns. It is important for physicians to understand the types of events that may cause patients to inquire about certain treatments for better quality health information and clinical visits.展开更多
目的观察并探讨“五步法”经尿道钬激光前列腺剜除术(Holmium laser enucleation of prostate,HoLEP)处理大体积前列腺增生对尿控及性功能保护的影响。方法回顾性分析自2021年6月至2024年5月合肥市第一人民医院收治的105例大体积前列腺...目的观察并探讨“五步法”经尿道钬激光前列腺剜除术(Holmium laser enucleation of prostate,HoLEP)处理大体积前列腺增生对尿控及性功能保护的影响。方法回顾性分析自2021年6月至2024年5月合肥市第一人民医院收治的105例大体积前列腺增生患者的资料,其中52例行“五步法”HoLEP术治疗;53例以双极等离子前列腺剜除术(transurethral plasma kinetic enucleation of the prostate,TUKEP)治疗。收集患者围手术期相关指标,并观察两组患者术后尿失禁发生率及性功能改变情况[逆行射精发生率及国际勃起功能指数-5(International Index of Erectile Function-5,IIEF-5)评分],比较两组患者术前与术后6个月最大尿流率(maximum flow rate,Qmax)、国际前列腺症状评分(International Prostate Symptom Score,IPSS)、生活质量评分(quality of life,QOL)、前列腺特异性抗原(prostate specific antigen,PSA)等指标变化情况。结果两组患者围手术期留置尿管时间、切除腺体质量的比较差异均无统计学意义;HoLEP组血红蛋白下降值、手术时间均少于TUKEP组(P<0.05)。两组患者术后5 d血清C反应蛋白均高于术前(P<0.05),但HoLEP组低于TUKEP组(P<0.05)。所有患者术后随访6个月,两组间Qmax、PSA、IPSS、QOL及IIEF-5差异均无统计学意义;短暂性尿失禁、逆行射精发生率比较,HoLEP组明显优于TUKEP组(P<0.05)。结论“五步法”HoLEP术式治疗大体积前列腺增生手术疗效良好,具有术后并发症少、恢复快等优点。在达到同样疗效的情况下,对尿控及性功能保护较好,值得推广。展开更多
The 2-1μm thulium laser resection of the prostate-tangerine technique （TmLRP-TT） has been introduced as a minimally invasive treatment for benign prostatic hyperplasia （BPH）. This study was undertaken to assess t...The 2-1μm thulium laser resection of the prostate-tangerine technique （TmLRP-TT） has been introduced as a minimally invasive treatment for benign prostatic hyperplasia （BPH）. This study was undertaken to assess the clinical efficacy and safety of TmLRP-TT for the treatment of BPH patients with previously negative transrectal prostate biopsy. A prospective analysis of 51 patients with previously negative transrectal prostate biopsy who underwent surgical treatment using TmLRP-TT was performed from December 2011 to December 2013. Preoperative status, surgical details, and perioperative complications were recorded. The follow-up outcome was evaluated with subjective and objective tests at I and 6 months. TmLRP-TT was successfully completed in all patients. Mean prostate volume, operative duration, and catheterization time were 93.3 ± 37.9 ml, 69.5 ± 39.5 min, and 6.5 ± 1.3 days, respectively. The mean International Prostate Symptom Score, quality of life score, maximum urinary flow rate, and post-void residual urine volume changed notably at 6-month follow-up （22.5 ± 6.9 vs 6.1 ± 3.2, 4.8 ± 1.3 vs 1.1 ± 0.9, 7.3 ± 4.5 vs 18.9 ± 7.1 ml s^-1, and 148.7 ± 168.7 vs 28.4 ± 17.9 ml）. Two （3.9%） patients required blood transfusion perioperatively, while 3 （5.9%） patients experienced transient hematuria postoperatively, and 2 （3.9%） patients received 3 days recatheterization due to clot retention. TmLRP-TT is a safe and effective minimally invasive technique for patients with previously negative transrectal prostate biopsy during the 6-month follow-up. This promising technology may be a feasible surgical method for previously negative transrectal prostate biopsy in the future.展开更多
目的:分析倒Y形保留功能尿道钬激光前列腺剜除术对术后尿失禁的影响。方法:收集了2022年6月至2023年5月在武汉大学人民医院泌尿外科住院的109例良性前列腺增生患者的相关临床资料,进行回顾性分析。采用计算机生成的随机数字表来进行随...目的:分析倒Y形保留功能尿道钬激光前列腺剜除术对术后尿失禁的影响。方法:收集了2022年6月至2023年5月在武汉大学人民医院泌尿外科住院的109例良性前列腺增生患者的相关临床资料,进行回顾性分析。采用计算机生成的随机数字表来进行随机分组,将患者随机分为两组,A组52例进行传统保留前列腺尖部尿道瓣膜的钬激光前列腺剜除技术,B组57例进行倒Y形保留功能尿道钬激光前列腺剜除术。记录术中及术后相关指标。根据国际尿失禁状态推荐的标准,对患者尿失禁状态和排尿后症状进行评价。结果:B组拔管后压力性尿失禁率为10.52%,显著低于A组的26.92%(P=0.027);B组术后2周有1.75%的尿失禁率,而A组术后2周的尿失禁率为11.54%,A组尿失禁率明显高于B组(P=0.037);B组术后1个月尿失禁率同样明显低于A组(0 vs 7.69%,P=0.033)。结论:使用倒Y形保留功能尿道钬激光前列腺剜除术治疗良性前列腺增生相较于传统保留前列腺尖部尿道瓣膜的钬激光前列腺剜除术,能够使患者术后压力性尿失禁情况有较为明显的改善。展开更多
Background： This study compared the efficacy and safety between 120-W thulium：yttrium-aluminum-garnet （Tm：YAG） vapoenucleation of prostates （ThuVEP） and holmium laser enucleation of prostates （HoLEP） for pati...Background： This study compared the efficacy and safety between 120-W thulium：yttrium-aluminum-garnet （Tm：YAG） vapoenucleation of prostates （ThuVEP） and holmium laser enucleation of prostates （HoLEP） for patients with lower urinary tract symptoms （LUTS） due to benign prostatic hyperplasia （BPH）. Methods： A retrospective analysis of 88 consecutive patients with symptomatic BPH was carried out, who underwent either 120-W ThuVEP or HoLEP nonrandomly. Patient demographics and peri-operative and 12-month follow-up data were analyzed with the International Prostate Symptom Score （IPSS）, quality of life （QoL） score, maximum flow rate （Qmax）, postvoid residual urine volume （PVR）＋ and rates of peri-operative and late complications. Results： The patients in each group showed no significant difference in preoperative parameters. Compared with the HoLEP group, patients in the 120-W ThuVEP group required significantly shorter time for laser enucleation （58.3 ± 12.8 min vs. 70.5 ± 22.3 min, P = 0.003）, and resulted in a significant superiority in laser efficiency （resected prostate weight/laser enucleation time） for 120-W Tm：YAG laser compared to holmium：YAG laser （0.69 ± 0.18 vs. 0.61 ± 0.19, P = 0.048）. During 1, 6, and 12 months of follow-ups, the procedures did not demonstrate a significant difference in IPSS, QoL score, Qmax, or PVR （P 〉 0.05）. Mean peri-operative decrease of hemoglobin in the HoLEP group was similar to the ThuVEP group （ 17.1 ± 12.0 g/L vs. 15.2± 10.1 g/L, P = 0.415）. Early and late incidences of complications were low and did not differ significantly between the two groups of 120-W ThuVEP and HoLEP patients （P 〉 0.05）. Conclusions： 120-W ThuVEP and HoLEP are potent, safe and efficient modalities of minimally invasive surgeries for patients with LUTS due to BPH. Compared with HoLEP, 120-W TbuVEP offers advantages of reduction of laser enucleation time and improvement of laser efficiency.展开更多
目的:分析高龄良性前列腺增生患者围术期并发症情况及其危险因素。方法:回顾性分析北京大学第一医院泌尿外科2013年1月至2023年1月接受经尿道前列腺增生手术的患者3597例,纳入年龄≥80岁的高龄患者430例(中位年龄82岁),其中接受经尿道...目的:分析高龄良性前列腺增生患者围术期并发症情况及其危险因素。方法:回顾性分析北京大学第一医院泌尿外科2013年1月至2023年1月接受经尿道前列腺增生手术的患者3597例,纳入年龄≥80岁的高龄患者430例(中位年龄82岁),其中接受经尿道前列腺电切术患者346例,经尿道激光前列腺剜除术患者84例。83例(19.3%)患者出现围术期并发症,347例(80.7%)患者无并发症发生。采用Clavien-Dindo分级统计围术期并发症的发生率、类型及严重程度;使用单因素和多因素Logistic分析探究围术期并发症及发生率较高的并发症的危险因素。结果:与无并发症的患者相比,出现围术期并发症的患者中位住院时间(3 d vs.4 d)和术后尿管中位拔除时间(4 d vs.6 d)明显延长(P均<0.001)。多因素回归分析示,切除组织重量(OR=1.011,95%CI:1.001~1.020,P=0.026)、糖尿病(OR=1.946,95%CI:1.096~3.455,P=0.023)及术前尿潴留(OR=1.784,95%CI:1.049~3.032,P=0.033)与高龄患者围术期并发症存在相关性。出血和感染是最常见的围术期并发症,多因素回归分析示,出血与手术方式(OR=0.207,95%CI:0.056~0.768,P=0.019)和切除组织重量(OR=1.031,95%CI:1.019~1.044,P<0.001)相关;术后感染与糖尿病(OR=2.624,95%CI:1.187~5.804,P=0.017)和手术时间(OR=1.011,95%CI:1.002~1.020,P=0.015)相关。根据Clavien-Dindo并发症分级:I级15例(3.5%),其中前列腺电切术11例,激光前列腺剜除术4例;II级61例(14.2%),其中接受前列腺电切术48例,接受激光前列腺剜除术13例;Ⅲ级及Ⅳ级7例(1.6%),均发生于前列腺电切术患者;未出现V级并发症。结论:切除组织重量、糖尿病、术前尿潴留和手术时间是高龄患者接受经尿道前列腺增生手术后发生围术期并发症的独立危险因素。对于高龄患者,经尿道激光前列腺剜除术的围术期Ⅲ、Ⅳ级严重并发症和出血相关并发症的发生率较低,该手术方式更适用于需手术治疗的高龄前列腺增生患者。展开更多
目的分析经尿道钬激光前列腺剜除术(HoLEP)治疗低龄前列腺增生的临床效果。方法选取2021年4月-2024年1月玉林市红十字会医院泌尿外科收治的60例低龄(≤65岁)前列腺增生患者,根据治疗方式不同分为观察组和对照组各30例。观察组应用HoLEP...目的分析经尿道钬激光前列腺剜除术(HoLEP)治疗低龄前列腺增生的临床效果。方法选取2021年4月-2024年1月玉林市红十字会医院泌尿外科收治的60例低龄(≤65岁)前列腺增生患者,根据治疗方式不同分为观察组和对照组各30例。观察组应用HoLEP治疗,对照组应用经尿道前列腺电切术(TURP)治疗。比较两组手术情况,手术前后国际前列腺症状评分(IPSS),术后3和6个月尿流动力学指标、炎症应激指标、性功能指标。结果观察组膀胱冲洗时间短于对照组;术后3个月观察组IPSS评分低于对照组,膀胱残余尿量与最大尿流率高于对照组;术后3和6个月观察组的国际勃起功能指数问卷5项(IIEF-5)评分高于对照组,逆行射精率低于对照组,且观察组术后3个月与术前、术后6个月与术前、术后3个月与6个月IIEF-5评分差值高于对照组(P<0.05)。两组患者术前与术后12、24 h C反应蛋白水平比较,差异无统计学意义(P>0.05)。结论低龄前列腺增生患者应用HoLEP治疗效果显著,在解除下尿路梗阻的同时保护性功能方面具独特的优势。展开更多
目的比较钬激光剜除术(HoLEP)与铥激光剜除术(ThULEP)治疗良性前列腺增生的疗效及安全性。方法检索PubMed、EMbase、The Cochrane Library、Web of Science、中国知网、万方数据库、维普数据库,收集HoLEP与ThULEP治疗良性前列腺增生的...目的比较钬激光剜除术(HoLEP)与铥激光剜除术(ThULEP)治疗良性前列腺增生的疗效及安全性。方法检索PubMed、EMbase、The Cochrane Library、Web of Science、中国知网、万方数据库、维普数据库,收集HoLEP与ThULEP治疗良性前列腺增生的临床研究,检索时间为建库至2024年4月。采用Cochrane偏倚风险评估工具对纳入文献进行方法学质量评价,利用RevMan 5.4.1软件对纳入数据进行统计学分析。结果共纳入11篇文献,涉及良性前列腺增生患者2029例。meta分析结果显示,HoLEP与ThULEP患者残余尿量(PVR)、国际前列腺症状评分(IPSS)、生活质量评分(QOL)、最大尿流率(Qmax)、前列腺特异性抗原(PSA)、并发症发生率、手术时间及拔管时间比较,差异均无统计学意义(均P>0.05)。HoLEP患者剜除时间长于ThULEP患者,术中出血量多于ThULEP患者(均P<0.05),且各研究间患者术后PVR、IPSS、QOL、Qmax、PSA、并发症发生率、剜除时间及拔管时间无异质性(I^(2)=0%~46%),手术时间存在异质性(I^(2)=92%)。结论HoLEP与ThULEP治疗良性前列腺增生的效果及安全性相似,但相比HoLEP,ThULEP的剜除时间更短,术中出血量更少。展开更多
文摘Objective:To provide the first large single-operator case series of patients who undergo“en bloc”thulium laser enucleation of the prostate(ThuLEP)and to demonstrate an improvement in enucleation efficacy with experience.Methods:We prospectively evaluated a cohort of patients with symptomatic benign prostatic hyperplasia(BPH)who underwent“en bloc”ThuLEP between May 2015 and November 2017.Association between dependent variables(delivered energy and operating time)and independent variables(adenoma volume and experience)were estimated with regression analysis.The experience was calculated as the time interval between the date of the first operation of the series and the date of the operation being considered.Results:A total of 100 patients were registered for the study.Median operative time was 56.5 min(interquartile range[IQR]:40-85 min).Median enucleation time was 17.4 min(IQR:15-21.5 min).Median enucleation index(enucleation time per adenoma gram)was 0.3 min/g(0.2-0.3 min/g).The overall operative time is not influenced by experience,but we registered a significant trend towards a reduction in the total amount of energy delivered energy normalized per adenoma gram(p=0.0148).Conclusion:We believe that further attention is needed for these new“en bloc”prostatic enucleation techniques,which can facilitate some surgical steps,leading to a widespread use of laser technology for BPH surgical treatment.
文摘Treatment of patients with lower urinary tract symptoms （LUTS） secondary to benign prostatic hyperplasia （BPH） may affect the quality of sexual function and ejaculation. The effect of new surgical procedures, which are currently available to treat BPH, on erection and ejaculation, has been poorly studied. This study aimed to assess the effect of thulium laser enucleation of the prostate （ThuLEP） on sexual function and retrograde ejaculation in patients with LUTS secondary to BPH. We performed a prospective study in 110 consecutive patients who had undergone ThuLEP to analyze changes in sexual function and urinary symptoms. To evaluate changes in erection and ejaculation, and the effect of urinary symptoms on the quality of life （QoL）, five validated questionnaires were used： the ICIQ-MLUTSsex, MSHQ-EjD, International Index of Erectile Function 5, International Prognostic Scoring System （IPSS） questionnaire, and QoL index of the intraclass correlation coefficients. Patients also underwent IPSS and flowmetry to assess the outcome of flow. Patients were evaluated before surgery and 3-6 months after ThuLEP, whereas those with previous abdominal surgery were excluded. The patients＇ mean age was 67.83 years. Postoperative urinary symptoms improved after surgery. No significant differences in erectile function before and after surgery were observed. As compared with other techniques described in the literature, the percentage of patients with conserved ejaculation increased by 52.7% after ThuLEP. ThuLEP positively affects urinary symptoms and their effect on the QoL of patients as assessed by questionnaire scores. While endoscopic management of BPH （e.g. transurethral resection of the prostate） causes retrograde ejaculation in most patients, those who undergo ThuLEP have conserved ejaculation and erectile function.
文摘Objective:The aim of this research was to evaluate the efficiency of reciprocating morcellation for removing giant benign prostatic hyperplasia during holmium laser enucleation of the prostate,investigate whether performing morcellation as a two-stage procedure improves tissue retrieval efficiency,and seek to determine the optimal interval between the two surgeries.Methods:This study included nine cases of holmium laser enucleation of the prostate with an enucleated prostate weight exceeding 200 g,indicative of substantial prostate enlargement.Morcellation was performed on Day 0(n=4),Day 4(n=1),Day 6(n=1),and Day 7(n=3).The intervals were compared regarding the morcellation efficiency,beach ball presence,and pathology.Results:The mean estimated prostate volume was 383(range 330e528)mL;the median enucleation weight was 252(interquartile range[IQR]222,342)g;and the median enucleation time was 83(IQR 62,100)min.The mean morcellation efficiency was 1.44(SD 0.55)g/min on Day 0 and 13.69(SD 2.46)g/min on day 7.The morcellation efficiency was 4.15 g/min and 10.50 g/min on Day 4 and Day 6,respectively,with significantly higher in the two-stage group compared to one-stage group(11.0 g/min vs.1.5 g/min;p=0.014).Efficiency was strongly correlated with intervals(p<0.001);the incidences of beach balls were 100%(4/4)and 60%(3/5)in the immediate and two-stage surgery groups,respectively.Conclusion:The efficiency of two-stage morcellation with reciprocating morcellators was highly related to the postoperative interval,with the maximum efficiency reached on Day 7.
文摘Two-micron （thulium） laser resection of the prostate-tangerine technique （TmLRP-TT） is a transurethral procedure that uses a thulium laser fiber to dissect whole prostatic lobes off the surgical capsule, similar to peeling a tangerine. We recently reported the primary results. Here we introduce this procedure in detail. A 70-W, 2-um （thulium） laser was used in continuous-wave mode. We joined the incision by making a transverse cut from the level of the verumontanum to the bladder neck, making the resection sufficiently deep to reach the surgical capsule, and resected the prostate into small pieces, just like peeling a tangerine. As we resected the prostate, the pieces were vaporized, sufficiently small to be evacuated through the reseetoscope sheath, and the use of the mechanical tissue morcellator was not required. The excellent hemostasis of the thulium laser ensured the safety of TmLRP-TT. No patient required blood transfusion. Saline irrigation was used intraoperatively, and no case of transurethral resection syndrome was observed. The bladder outlet obstruction had clearly resolved after catheter removal in all cases. We designed the tangerine technique and proved it to be the most suitable procedure for the use of thulium laser in the treatment of benign prostatic hyperplasia （BPH）. This procedure, which takes less operative time than standard techniques, is safe and combines efficient cutting and rapid organic vaporization, thereby showing the great superiority of the thulium fiber laser in the treatment of BPH. It has been proven to be as safe and efficient as transurethral resection of the prostate （TURP） during the 1-year follow-up.
基金Supported by the Kunshan Research and Development Project,No.KSZ2203the Kunshan Research and Development Project,No.KZYY2205.
文摘BACKGROUND Primary prostate Burkitt's lymphoma is a rare and aggressive condition with a poor prognosis.Its clinical presentation can be challenging to differentiate from benign prostatic hyperplasia.Given the rarity of primary prostate Burkitt's lymphoma,its diagnosis and treatment remain unclear.CASE SUMMARY This report presents a case of a 57-year-old male with primary prostate Burkitt's lymphoma,initially misdiagnosed as prostatic hyperplasia.This case's operative process,intraoperative findings and postoperative management are discussed in detail.CONCLUSION Primary prostate lymphoma is difficult to distinguish from other prostate diseases.Holmium laser enucleation of the prostate(HoLEP),a minimally invasive procedure,is crucial in diagnosing and treating this rare disease.Clinicians should remain vigilant and thoroughly combine physical examination,imaging and test results when encountering patients of younger age with small prostate size but a rapid progression of lower urinary tract symptoms.HoLEP is an essential diagnostic and therapeutic tool in managing primary prostate Burkitt's lymphoma.
文摘Objective:We aimed to determine safety and feasibility of thulium laser transurethral vapoenucleation of prostate(ThuVEP)for treatment of obese patients affected by benign prostatic hyperplasia(BPH).Methods:We retrospectively analysed data of 452 patients with BPH who underwent ThuVEP from February 2012 to March 2016 in a single center.Patients were divided into three groups according to body mass index(BMI,kg/m^2):Normal weight(18.5≤BMI<25;Group A),overweight(25≤BMI<30;Group B)and obese(BMI≤30;Group C),for a total of 412 patients evaluable for this study.Preoperative total serum prostate-specific antigen(PSA),digital rectal examination of the prostate,transrectal ultrasound(TRUS),renal ultrasound,urine culture,uroflowmetry,International Prostate Symptoms Score(IPSS),and Quality of Life(QoL)score were analyzed.Post-operative complications,hospital stay and days of catheterization,questionnaires and uroflowmetry at 1 and 3 months after surgery were evaluated.Preoperative data,surgical outcomes,complication rate and clinical outcomes were compared between groups.Results:The median age of patients was 69 years(Interquartile Range[IQR 10]).The preoperative median IPSS among groups was 19(IQR 8.75),20(IQR 10),and 18(IQR 10)respectively.At 1 and 3 months of follow-up,this value was 8(IQR 7),8(IQR 4),7(IQR 5)and 5(IQR 6.25),5(IQR 6),6(IQR 5),respectively(all p between groups>0.05).There was no statistically significant difference among three groups as for hospital stay and days of catheterization(p>0.05).Conclusion:Our results showed that ThuVEP was safe and feasible even in overweight patients with substantially enlarged prostate.
文摘Objective To investigate the feasibility and efficacy of transurethral prostate enucleation with 2 μm laser in treatment of benign prostatic hyperplasia ( BPH) . Methods One hundred and seven patients with BPH were treated by transurethral prostate enucleation with 2 μm la-
文摘We aim to evaluate the incidence of incontinence following laser endoscopic enucleation of the prostate(EEP)comparing en-bloc(Group 1)versus 2-lobe/3-lobe techniques(Group 2).We performed a retrospective review of patients undergoing EEP for benign prostaticenlargement in 12 centers between January 2020 and January 2022.Data were presented as median and interquartile range(IQR).Univariable and multivariable logistic regression analysis was performed to evaluate factors associated with stress urinary incontinence(SUI)and mixed urinary incontinence(MUI).There were 1711 patients in Group 1 and 3357 patients in Group 2.Patients in Group 2were significantly younger(68[62–73]years vs 69[63–74]years,P=0.002).Median(interquartile range)prostate volume(PV)wassimilar between the groups(70[52–92]ml in Group 1 vs 70[54–90]ml in Group 2,P=0.774).There was no difference in preoperativeInternational Prostate Symptom Score,quality of life,or maximum flow rate.Enucleation,morcellation,and total surgical time weresignificantly shorter in Group 1.Within 1 month,overall incontinence rate was 6.3%in Group 1 versus 5.3%in Group 2(P=0.12),and urge incontinence was significantly higher in Group 1(55.1%vs 37.3%in Group 2,P<0.001).After 3 months,the overall rate ofincontinence was 1.7%in Group 1 versus 2.3%in Group 2(P=0.06),and SUI was significantly higher in Group 2(55.6%vs 24.1%in Group 1,P=0.002).At multivariable analysis,PV and IPSS were factors significantly associated with higher odds of transient SUI/MUI.PV,surgical time,and no early apical release technique were factors associated with higher odds of persistent SUI/MUI.
文摘Objective:Urethral stricture disease after endo-urological treatment of benign prostatic hyperplasia(BPH)is a sparsely described complication.We describe management of five categories of these strictures in this retrospective observational case series.Methods:One hundred and twenty-one patients presenting with symptoms of bladder outflow obstruction after endo-urological intervention for BPH from February 2016 to March 2019 were evaluated.Among them,76 were eligible for this study and underwent reconstructive surgery.Preoperative and postoperative assessments were done with symptom scores,uroflowmetry,ultrasound for post-void residue,and urethrogram.Any intervention during follow-up was classed as a failure.The recurrence and 95%confidence interval for recurrence percentage were calculated.Results:The following five categories of patients were identified:Bulbo-membranous(33[43.4%]),navicular fossa(21[27.6%]),penile/peno-bulbar(8[10.5%]),bladder neck stenosis(6[7.9%]),and multiple locations(8[10.5%]).The average age was 69 years(range:60-84 years).Overall average symptom score,flow rate,and post-void residue changed from 21 to 7,6 mL/s to 19 mL/s,and 210 mL to 20 mL,respectively.The average follow-up was 34 months(range:12-58 months).Overall recurrence and complication rates were 10.5%and 9.2%,respectively.The recurrence in each category was seen in 3,1,2,1,and 1 patient,respectively.Overall 95% confidence interval for recurrence percentage was 4.66-19.69.Conclusion:Urethral stricture disease is a major long-term complication of endo-urological treatment of BPH.The bulbo-membranous strictures need continence preserving approach.Navicular fossa strictures require minimally invasive and cosmetic consideration.Peno-bulbar strictures require judicious use of grafts and flaps.Bladder neck stenosis in this cohort could be treated with endoscopic measures.Multiple locations need treatment based on their sites in single-stage as far as possible.
文摘Objective:Minimally invasive treatments for benign prostatic hyperplasia (BPH) have seen an increase in usage in recent years. We aimed to determine what types of events may influence patient search habits related to surgical BPH treatments.Methods:Google Trends was used to determine the frequency of searches for different minimally invasive and prostatic ablative treatments for BPH in the United States. The procedures including transurethral resection of the prostate (TURP), Aquablation therapy (Aquablation), Greenlight laser therapy (Greenlight), transurethral needle ablation, transurethral microwave thermotherapy, Urolift (prostatic urethral lift [PUL]), Rezum, iTind, holmium laser enucleation of the prostate, simple prostatectomy, and prostatic artery embolization were compared.Results:From January 1, 2004 to February 28, 2023, the number of internet search queries have increased for TURP, PUL, Rezum, prostatic artery embolization, and holmium laser enucleation of the prostate. There has been a slight decrease in searches for Greenlight, transurethral needle ablation, transurethral microwave thermotherapy, iTind, simple prostatectomy, and Aquablation.Conclusion:Despite increased searches of alternatives, TURP remains the most searched BPH procedure. Additionally, search habits may be influenced by several factors including government approval, corporate acquisition, and marketing campaigns. It is important for physicians to understand the types of events that may cause patients to inquire about certain treatments for better quality health information and clinical visits.
文摘目的观察并探讨“五步法”经尿道钬激光前列腺剜除术(Holmium laser enucleation of prostate,HoLEP)处理大体积前列腺增生对尿控及性功能保护的影响。方法回顾性分析自2021年6月至2024年5月合肥市第一人民医院收治的105例大体积前列腺增生患者的资料,其中52例行“五步法”HoLEP术治疗;53例以双极等离子前列腺剜除术(transurethral plasma kinetic enucleation of the prostate,TUKEP)治疗。收集患者围手术期相关指标,并观察两组患者术后尿失禁发生率及性功能改变情况[逆行射精发生率及国际勃起功能指数-5(International Index of Erectile Function-5,IIEF-5)评分],比较两组患者术前与术后6个月最大尿流率(maximum flow rate,Qmax)、国际前列腺症状评分(International Prostate Symptom Score,IPSS)、生活质量评分(quality of life,QOL)、前列腺特异性抗原(prostate specific antigen,PSA)等指标变化情况。结果两组患者围手术期留置尿管时间、切除腺体质量的比较差异均无统计学意义;HoLEP组血红蛋白下降值、手术时间均少于TUKEP组(P<0.05)。两组患者术后5 d血清C反应蛋白均高于术前(P<0.05),但HoLEP组低于TUKEP组(P<0.05)。所有患者术后随访6个月,两组间Qmax、PSA、IPSS、QOL及IIEF-5差异均无统计学意义;短暂性尿失禁、逆行射精发生率比较,HoLEP组明显优于TUKEP组(P<0.05)。结论“五步法”HoLEP术式治疗大体积前列腺增生手术疗效良好,具有术后并发症少、恢复快等优点。在达到同样疗效的情况下,对尿控及性功能保护较好,值得推广。
文摘The 2-1μm thulium laser resection of the prostate-tangerine technique （TmLRP-TT） has been introduced as a minimally invasive treatment for benign prostatic hyperplasia （BPH）. This study was undertaken to assess the clinical efficacy and safety of TmLRP-TT for the treatment of BPH patients with previously negative transrectal prostate biopsy. A prospective analysis of 51 patients with previously negative transrectal prostate biopsy who underwent surgical treatment using TmLRP-TT was performed from December 2011 to December 2013. Preoperative status, surgical details, and perioperative complications were recorded. The follow-up outcome was evaluated with subjective and objective tests at I and 6 months. TmLRP-TT was successfully completed in all patients. Mean prostate volume, operative duration, and catheterization time were 93.3 ± 37.9 ml, 69.5 ± 39.5 min, and 6.5 ± 1.3 days, respectively. The mean International Prostate Symptom Score, quality of life score, maximum urinary flow rate, and post-void residual urine volume changed notably at 6-month follow-up （22.5 ± 6.9 vs 6.1 ± 3.2, 4.8 ± 1.3 vs 1.1 ± 0.9, 7.3 ± 4.5 vs 18.9 ± 7.1 ml s^-1, and 148.7 ± 168.7 vs 28.4 ± 17.9 ml）. Two （3.9%） patients required blood transfusion perioperatively, while 3 （5.9%） patients experienced transient hematuria postoperatively, and 2 （3.9%） patients received 3 days recatheterization due to clot retention. TmLRP-TT is a safe and effective minimally invasive technique for patients with previously negative transrectal prostate biopsy during the 6-month follow-up. This promising technology may be a feasible surgical method for previously negative transrectal prostate biopsy in the future.
文摘目的:分析倒Y形保留功能尿道钬激光前列腺剜除术对术后尿失禁的影响。方法:收集了2022年6月至2023年5月在武汉大学人民医院泌尿外科住院的109例良性前列腺增生患者的相关临床资料,进行回顾性分析。采用计算机生成的随机数字表来进行随机分组,将患者随机分为两组,A组52例进行传统保留前列腺尖部尿道瓣膜的钬激光前列腺剜除技术,B组57例进行倒Y形保留功能尿道钬激光前列腺剜除术。记录术中及术后相关指标。根据国际尿失禁状态推荐的标准,对患者尿失禁状态和排尿后症状进行评价。结果:B组拔管后压力性尿失禁率为10.52%,显著低于A组的26.92%(P=0.027);B组术后2周有1.75%的尿失禁率,而A组术后2周的尿失禁率为11.54%,A组尿失禁率明显高于B组(P=0.037);B组术后1个月尿失禁率同样明显低于A组(0 vs 7.69%,P=0.033)。结论:使用倒Y形保留功能尿道钬激光前列腺剜除术治疗良性前列腺增生相较于传统保留前列腺尖部尿道瓣膜的钬激光前列腺剜除术,能够使患者术后压力性尿失禁情况有较为明显的改善。
文摘Background： This study compared the efficacy and safety between 120-W thulium：yttrium-aluminum-garnet （Tm：YAG） vapoenucleation of prostates （ThuVEP） and holmium laser enucleation of prostates （HoLEP） for patients with lower urinary tract symptoms （LUTS） due to benign prostatic hyperplasia （BPH）. Methods： A retrospective analysis of 88 consecutive patients with symptomatic BPH was carried out, who underwent either 120-W ThuVEP or HoLEP nonrandomly. Patient demographics and peri-operative and 12-month follow-up data were analyzed with the International Prostate Symptom Score （IPSS）, quality of life （QoL） score, maximum flow rate （Qmax）, postvoid residual urine volume （PVR）＋ and rates of peri-operative and late complications. Results： The patients in each group showed no significant difference in preoperative parameters. Compared with the HoLEP group, patients in the 120-W ThuVEP group required significantly shorter time for laser enucleation （58.3 ± 12.8 min vs. 70.5 ± 22.3 min, P = 0.003）, and resulted in a significant superiority in laser efficiency （resected prostate weight/laser enucleation time） for 120-W Tm：YAG laser compared to holmium：YAG laser （0.69 ± 0.18 vs. 0.61 ± 0.19, P = 0.048）. During 1, 6, and 12 months of follow-ups, the procedures did not demonstrate a significant difference in IPSS, QoL score, Qmax, or PVR （P 〉 0.05）. Mean peri-operative decrease of hemoglobin in the HoLEP group was similar to the ThuVEP group （ 17.1 ± 12.0 g/L vs. 15.2± 10.1 g/L, P = 0.415）. Early and late incidences of complications were low and did not differ significantly between the two groups of 120-W ThuVEP and HoLEP patients （P 〉 0.05）. Conclusions： 120-W ThuVEP and HoLEP are potent, safe and efficient modalities of minimally invasive surgeries for patients with LUTS due to BPH. Compared with HoLEP, 120-W TbuVEP offers advantages of reduction of laser enucleation time and improvement of laser efficiency.
文摘目的:分析高龄良性前列腺增生患者围术期并发症情况及其危险因素。方法:回顾性分析北京大学第一医院泌尿外科2013年1月至2023年1月接受经尿道前列腺增生手术的患者3597例,纳入年龄≥80岁的高龄患者430例(中位年龄82岁),其中接受经尿道前列腺电切术患者346例,经尿道激光前列腺剜除术患者84例。83例(19.3%)患者出现围术期并发症,347例(80.7%)患者无并发症发生。采用Clavien-Dindo分级统计围术期并发症的发生率、类型及严重程度;使用单因素和多因素Logistic分析探究围术期并发症及发生率较高的并发症的危险因素。结果:与无并发症的患者相比,出现围术期并发症的患者中位住院时间(3 d vs.4 d)和术后尿管中位拔除时间(4 d vs.6 d)明显延长(P均<0.001)。多因素回归分析示,切除组织重量(OR=1.011,95%CI:1.001~1.020,P=0.026)、糖尿病(OR=1.946,95%CI:1.096~3.455,P=0.023)及术前尿潴留(OR=1.784,95%CI:1.049~3.032,P=0.033)与高龄患者围术期并发症存在相关性。出血和感染是最常见的围术期并发症,多因素回归分析示,出血与手术方式(OR=0.207,95%CI:0.056~0.768,P=0.019)和切除组织重量(OR=1.031,95%CI:1.019~1.044,P<0.001)相关;术后感染与糖尿病(OR=2.624,95%CI:1.187~5.804,P=0.017)和手术时间(OR=1.011,95%CI:1.002~1.020,P=0.015)相关。根据Clavien-Dindo并发症分级:I级15例(3.5%),其中前列腺电切术11例,激光前列腺剜除术4例;II级61例(14.2%),其中接受前列腺电切术48例,接受激光前列腺剜除术13例;Ⅲ级及Ⅳ级7例(1.6%),均发生于前列腺电切术患者;未出现V级并发症。结论:切除组织重量、糖尿病、术前尿潴留和手术时间是高龄患者接受经尿道前列腺增生手术后发生围术期并发症的独立危险因素。对于高龄患者,经尿道激光前列腺剜除术的围术期Ⅲ、Ⅳ级严重并发症和出血相关并发症的发生率较低,该手术方式更适用于需手术治疗的高龄前列腺增生患者。
文摘目的分析经尿道钬激光前列腺剜除术(HoLEP)治疗低龄前列腺增生的临床效果。方法选取2021年4月-2024年1月玉林市红十字会医院泌尿外科收治的60例低龄(≤65岁)前列腺增生患者,根据治疗方式不同分为观察组和对照组各30例。观察组应用HoLEP治疗,对照组应用经尿道前列腺电切术(TURP)治疗。比较两组手术情况,手术前后国际前列腺症状评分(IPSS),术后3和6个月尿流动力学指标、炎症应激指标、性功能指标。结果观察组膀胱冲洗时间短于对照组;术后3个月观察组IPSS评分低于对照组,膀胱残余尿量与最大尿流率高于对照组;术后3和6个月观察组的国际勃起功能指数问卷5项(IIEF-5)评分高于对照组,逆行射精率低于对照组,且观察组术后3个月与术前、术后6个月与术前、术后3个月与6个月IIEF-5评分差值高于对照组(P<0.05)。两组患者术前与术后12、24 h C反应蛋白水平比较,差异无统计学意义(P>0.05)。结论低龄前列腺增生患者应用HoLEP治疗效果显著,在解除下尿路梗阻的同时保护性功能方面具独特的优势。
